Also trades as: PME.AX (ASX) · $vol 31M
PMCUF OTC
Pro Medicus Limited
1W: -5.0%
1M: -11.9%
3M: -23.2%
YTD: -24.9%
1Y: -46.2%
3Y: +112.7%
5Y: +164.8%
$108.86
-5.19 (-4.55%)
Weekly Expected Move ±4.7%
$99
$104
$109
$114
$119
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$136M
+22.5% ▲
5Y CAGR: +28.4%
Capital Expenditures
$443K
+94.0% ▲
5Y CAGR: -43.5%
Free Cash Flow
$136M
+30.7% ▲
5Y CAGR: +34.1%
Dividends Paid
$65M
-31.7% ▼
Buybacks
$10M
-28.9% ▼
Net Change in Cash
$44M
-6.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $44M | $61M | $83M | $0 | $265M |
| Depreciation & Amort. | $7M | $8M | $0 | $0 | $8M |
| Stock-Based Comp. | $32K | $1M | $2M | $0 | $0 |
| Change in Working Capital | $9M | -$6M | -$9M | $0 | $33M |
| Other Non-Cash Items | $18M | $30M | $7M | $111M | -$170M |
| Operating Cash Flow | $62M | $65M | $82M | $111M | $136M |
| — Investing Activities — | |||||
| Capital Expenditures | -$9M | -$6M | -$308K | -$439K | -$9M |
| Acquisitions (Net) | $17M | $7M | $0 | $0 | $0 |
| Investment Purchases | -$15M | -$21M | -$46M | -$33M | -$42M |
| Investment Sales | $6M | $18M | $39M | $30M | $29M |
| Other Investing | -$17M | -$7M | -$65M | -$3M | $0 |
| Investing Cash Flow | -$18M | -$10M | -$73M | -$7M | -$21M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$4M | -$845K | -$3M | -$8M | -$10M |
| Dividends Paid | -$19M | -$26M | -$37M | -$49M | -$65M |
| Other Financing | -$509K | -$574K | -$518K | -$651K | -$630K |
| Financing Cash Flow | -$23M | -$28M | -$40M | -$58M | -$75M |
| Net Change in Cash | $22M | $28M | -$31M | $47M | $44M |
| Cash End of Period | $64M | $91M | $60M | $107M | $146M |
| Free Cash Flow | $53M | $58M | $75M | $104M | $136M |